Martlet Capital is a Cambridge, United Kingdom-based venture capital firm focused on pre-seed and seed-stage investments in deep technology and life sciences startups. The firm provides patient capital to early-stage companies developing advanced technologies, including AI, quantum computing, semiconductors, and biotechnology. It typically invests in UK-based B2B ventures, often originating from university research or technical innovation ecosystems. Martlet Capital combines funding with strategic support, industry expertise, and network access to help companies scale from early development to exit. The firm operates as an early-stage venture investor with a focus on high-growth, science-driven businesses.